Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
GLYCOMIMETICS INC (GLYC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 9,167 shares
@ $1.5, valued at
$13.8k
|
|
| 10/03/2023 |
4
| Andrews Patricia S (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 8,167 shares
@ $1.5, valued at
$12.3k
|
|
| 10/03/2023 |
4
| King Rachel K. (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 6,667 shares
@ $1.5, valued at
$10k
|
|
| 05/18/2023 |
4
| Hahn Brian M. (SVP Finance, CFO) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Sold 3,700 shares
@ $1.95, valued at
$7.2k
|
|
| 05/11/2023 |
4
| JUNIUS DANIEL M (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Bought 30,000 shares
@ $1.56, valued at
$46.8k
|
|
| 05/09/2023 |
4
| Johnson Bruce S (SVP & Chief Commercial Officer) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Bought 13,500 shares
@ $1.57, valued at
$21.2k
|
|
| 02/28/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Bought 100,000 shares
@ $1.7, valued at
$170k
|
|
| 02/23/2023 |
4
| Invus Public Equities, L.P. (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Bought 50,000 shares
@ $1.85, valued at
$92.5k
Bought 150,000 shares
@ $1.7933, valued at
$269k
Bought 200,000 shares
@ $1.7538, valued at
$350.8k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2023 |
4
| Koenig Scott (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Exercised 10,500 options to buy
@ $2.55, valued at
$26.8k
|
|
| 01/27/2023 |
4
| SANDELL SCOTT D (10% Owner) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Sold 358,371 shares
@ $3.2639, valued at
$1.2M
Sold 293,645 shares
@ $3.2639, valued at
$958.4k
Sold 1,648,908 shares
@ $3.1188, valued at
$5.1M
Sold 1,351,092 shares
@ $3.1188, valued at
$4.2M
|
|
| 01/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2022 |
4
| Rock Edwin (Chief Medical Officer) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 200,000 options to buy
@ $0.74, valued at
$148k
|
|
| 05/20/2022 |
4
| PEARSON TIMOTHY R (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 21,000 options to buy
@ $0.6, valued at
$12.6k
|
|
| 05/20/2022 |
4
| Koenig Scott (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 21,000 options to buy
@ $0.6, valued at
$12.6k
|
|
| 05/20/2022 |
4
| King Rachel K. (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 21,000 options to buy
@ $0.6, valued at
$12.6k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2022 |
4
| Magnani John L. (SVP of Research, CSO) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Sold 3,227 shares
@ $1.09, valued at
$3.5k
|
|
| 03/10/2022 |
4
| Girard Armand (SVP, Chief Business Officer) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Sold 2,339 shares
@ $1.09, valued at
$2.5k
|
|
|
|
|